...
首页> 外文期刊>Homeopathy: the journal of the Faculty of Homeopathy >Preliminary investigation of metal and metalloid contamination of homeopathic products marketed in Croatia.
【24h】

Preliminary investigation of metal and metalloid contamination of homeopathic products marketed in Croatia.

机译:克罗地亚销售的顺势疗法产品的金属和类金属污染的初步调查。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Due to their popularity as a complementary therapy in many diseases, homeopathic products of animal, vegetable, mineral and chemical origin should be tested for the presence of contaminants to prevent eventual toxic effects. OBJECTIVE: Thirty samples of homeopathic products were analyzed to estimate possible contamination with potentially toxic elements: Pb, Cd, As, Hg, Cr, Ni and Zn, and to assess human exposure to these metals/metalloid as a consequence of their consumption. METHODS: Atomic absorption spectrometry was used to determine metal and metalloid concentrations. RESULTS: Most tested products had very low metal/metalloid levels (below the limit of quantification of the method), but the metal/metalloid levels in the remaining products were in the following ranges (in microg g(-1)): Pb 0.33-1.29 (6 samples), Cd 2.78 (1 sample), As 0.22 (1 sample), Hg 0.02-0.12 (24 samples), Cr 0.40-10.27 (10 samples), Ni 0.43-55.00 (19 samples), and Zn 2.20-27.80 (11 samples). In the absence of regulatory standards for homeopathic products, the obtained results were compared to maximum allowable levels (MALs) as proposed by USP Ad Hoc Advisory Panel. Some analyzed preparations had metal levels above MALs (Pb: 2 samples; Cd: 1 sample; Ni: 2 samples). However, estimated cumulative daily intakes from tested homeopathic products were in all cases lower than permitted daily exposures for all dosage forms. CONCLUSION: The risk of bioaccumulation of metals/metalloid from the homeopathic medicines seems to be rather low, due to small quantities of those products prescribed to be applied per day, as well as insignificant metal contamination of the majority of tested products. However, the fact that particular formulations were contaminated by metals above MALs indicates potential risk and points to the necessity of regular monitoring of homeopathic products for metal contamination, due to their frequent and mostly unsupervised use.
机译:背景:由于它们在许多疾病中作为辅助疗法的普及,应测试动物,植物,矿物质和化学来源的顺势疗法产品中是否存在污染物,以防止最终的毒性作用。目的:分析了30种顺势疗法产品样本,以评估潜在毒性元素Pb,Cd,As,Hg,Cr,Ni和Zn的可能污染,并评估人类因食用这些金属/准金属而产生的接触量。方法:采用原子吸收光谱法测定金属和准金属的浓度。结果:大多数被测产品的金属/准金属含量非常低(低于方法的定量限),但其余产品中的金属/准金属含量处于以下范围(以微克g(-1)为单位):Pb 0.33 -1.29(6个样品),Cd 2.78(1个样品),As 0.22(1个样品),Hg 0.02-0.12(24个样品),Cr 0.40-10.27(10个样品),Ni 0.43-55.00(19个样品)和Zn 2.20-27.80(11个样本)。在没有顺势疗法产品监管标准的情况下,将获得的结果与USP特设咨询小组建议的最大允许水平(MALs)进行比较。一些分析的制剂的金属含量高于MALs(Pb:2个样品; Cd:1个样品; Ni:2个样品)。但是,在所有情况下,测试过的顺势疗法产品的估计每日累积摄入量均低于所有剂型允许的每日摄入量。结论:顺势疗法药物中金属/类金属的生物蓄积风险似乎较低,这是由于规定每天要使用少量此类产品,并且大多数被测产品的金属污染很小。但是,特定制剂被MALs以上金属污染的事实表明了潜在的风险,并指出由于其频繁使用且大多是无监督使用,因此必须定期监测顺势疗法产品的金属污染情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号